Thromb Haemost 2010; 104(01): 186-188
DOI: 10.1160/TH09-12-0874
Letters to the Editor
Schattauer GmbH

Delayed massive pulmonary thromboembolic phenomenon following envenomation by Mojave rattlesnake (Crotalus scutulatus)

Ramesh Bhagat
1   Department of Pathology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
,
Kapil Sharma
2   Department of Emergency Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
,
Ravi Sarode
1   Department of Pathology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
,
Yu-Min Shen
3   Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
› Author Affiliations
Further Information

Publication History

Received: 30 December 2009

Accepted after minor revision: 12 February 2010

Publication Date:
23 November 2017 (online)

 
  • References

  • 1 Castro HC, Zingali RB, Albuquerque MG. et al Snake venom thrombin-like enzymes: from reptilase to now. Cell Mol Life Sci 2004; 61: 843-856.
  • 2 Markland FS. Snake venoms and the hemostatic system. Toxicon 1998; 36: 1749-1800.
  • 3 Matsui T, Fujimura Y, Titani K. Snake venom pro-teases affecting hemostasis and thrombosis. Biochim Biophys Acta 2000; 1477: 146-156.
  • 4 Clark RF, Williams SR, Nordt SP. et al Successful treatment of crotalid-induced neurotoxicity with a new polyspecific crotalid Fab antivenom. Ann Emerg Med 1997; 30: 54-57.
  • 5 Bronstein AC, Spyker DA, Cantilena Jr LR. et al 2006 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS). Clin Toxicol 2007; 45: 815-917.
  • 6 Glenn JL, Straight RC. Intergradation of two different venom populations of the Mojave rattlesnake (Crotalus scutulatus scutulatus) in Arizona. Toxicon 1989; 27: 411-418.
  • 7 Glenn JL, Straight RC, Wolfe MC, Hardy DL. Geographical variation in Crotalus scutulatus scutulatus (Mojave rattlesnake) venom properties. Toxicon 1983; 21: 119-130.
  • 8 Bush SP, Cardwell MD. Mojave rattlesnake (Crotalus scutulatus scutulatus) identification. Wilderness Environ Med 1999; 10: 6-9.
  • 9 Farstad D, Thomas T, Chow T. et al Mojave rattlesnake envenomation in southern California: a review of suspected cases. Wilderness Environ Med 1997; 08: 89-93.
  • 10 Hardy DL. Envenomation by the Mojave rattle-snake (Crotalus scutulatus scutulatus) in southern Arizona, U.S.A. Toxicon 1983; 21: 111-118.
  • 11 Jansen PW, Perkin RM, Van Stralen D. Mojave rattlesnake envenomation: prolonged neurotoxicity and rhabdomyolysis. Ann Emerg Med 1992; 21: 322-325.
  • 12 Hasiba U, Rosenbach LM, Rockwell D. et al DiC-like syndrome after envenomation by the snake, Crotalus horridus horridus. N Engl J Med 1975; 292: 505-507.
  • 13 Pirkle H, Theodor I, Miyada D. et al Thrombin-like enzyme from the venom of Bitis gabonica. Purification, properties, and coagulant actions. J Biol Chem 1986; 261: 8830-8835.
  • 14 Dempfle CE, Kohl R, Harenberg J. et al Coagulopathy after snake bite by Bothrops neuwiedi: case report and results of in vitro experiments. Blut 1990; 61: 369-374.
  • 15 Seifert SA, Boyer LV. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies. Ann Emerg Med 2001; 37: 189-195.
  • 16 Boyer LV, Seifert SA, Clark RF. et al Recurrent and persistent coagulopathy following pit viper envenomation. Arch Intern Med 1999; 159: 706-710.